Lucy Stafford is a medical cannabis patient and advocate. Having spent most of her teenage years in severe pain, dependent on opiates and a feeding tube, discovering medical cannabis has transformed her health and quality of life. She is passionate about working towards a healthcare system that integrates the use of medical cannabis in the …
By Dr. Shanna Marrinan Since the 2nd of March 2015, it has been illegal to drive with predetermined amounts of particular drugs (including legal medications) in your blood. The limits for these legal and illegal drugs can be located in ‘The Drug Driving (Specified Limits) (England and Wales) Regulations 2014’ (hereafter the 2014 regulations’). However, a handy …
The National Institute for Health and Care Excellence (NICE) published their guidance to clinicians on the 11th of November 2019 regarding the prescribing of Cannabis-Based Medicinal Products (CBMPs). Drug Science welcomes this news from NICE as it shows the start of a more rational approach to medical cannabis. However, it must be emphasised that this …
On the 1st of November 2018, medicinal cannabis products were removed from schedule 1 and placed in schedule 2 of the Misuse of Drugs Regulations 2001. This change in the law has left patients, medical professionals and law enforcement perplexed about who should and who should not have access to medicinal cannabis. As access to …
Professor David Nutt sits down with Joss Stone, Suzi Gage & Hannah Deacon to discuss the recent progress and biggest issues relating to medicinal cannabis. Many people up and down the country have turned to cannabis to alleviate pain & reduce symptoms of a wide range of ailments. Despite this, the drug still carries hefty penalties …
Drug Science is asked frequently about medical cannabis – what it is, what it can be used for, who can prescribe it and how to regulate it. We’ve developed different ways to help doctors, patients and professionals understand this complex, emerging field, and our education programmes are central to this MEDIC (Medical Education in Cannabinoids) …
At the end of last week, NICE released their initial appraisal on cannabidiol in the form of Epidiolex for childhood epilepsy. As predicted by Drug Science experts they found against it on the grounds of cost-benefit. We don’t have the company submission regarding cost/benefit analysis, and consequently cannot comment on those, but we can reflect …
The Royal College of Psychiatrists has undertaken a review to develop a College position on cannabis use in the UK and how this relates to mental health, incorporating evidence on the biological, psychological and social effects of cannabis, and the use of medicinal cannabis in relation to mental illness. The review invited comment from experts …
Drug Science is delighted to support The Cannabis Society Medical Conference, being held on 24th June in Central London. The Cannabis Society is dedicated to fostering the cannabis community through events, conferences, dinners and much more. The conference is an opportunity to join with doctors from both Europe and North America, industry experts, investors and …
Drug Science will launch the Working Medical Cannabis Working Group at its House of Lords annual evening reception on Wednesday 22 May 2019.
Please download the conference background materials here, including: Meeting slides DrugScience report on medicinal cannabis DrugScience cannabis pre-review submitted to the WHO Expert Committee on Drug Dependence Summaries of international and American medicinal cannabis licensing The Chief Medical Officer and advisor to the UK government has recently agreed that cannabis is a medicine. It has …